The report “Cardiac Marker Testing Market is on a robust growth trajectory, with a projected valuation of USD 7.7 billion by 2027, up from USD 5.0 billion in 2022, reflecting a notable Compound Annual Growth Rate (CAGR) of 8.7% during the forecast period. One of the driving …
The report “Cardiac Marker Testing Market by Product (Reagent, Instrument), Component (Troponin I & T, CK-MB, Myoglobin, BNP, hs-CRP), Disease (Myocardial Infarction, Congestive Heart Failure, Atheresclerosis), Enduser (Lab, PoC, Academia) – Global Forecast to 2027″, projected to reach USD 7.7 billion by 2027 from USD 5.0 billion …
Cardiac Marker Testing Market is projected to reach USD 7.7 billion by 2027 from USD 5.0 billion in 2022, at a CAGR of 8.7% during the forecast period. The major factors such as rising geriatric population globally and the subsequent increase in chronic heart conditions; the …